344 related articles for article (PubMed ID: 17724980)
1. [Bonus-malus regulations in the framework of the AVWG guideline-suitable migraine therapy are possible].
MMW Fortschr Med; 2007 May; 149 Suppl 2():102-3. PubMed ID: 17724980
[No Abstract] [Full Text] [Related]
2. Comparison of rizatriptan and sumatriptan.
O'Quinn S; Mansbach H; Salonen R
Headache; 1999 Jan; 39(1):59-60. PubMed ID: 18567177
[No Abstract] [Full Text] [Related]
3. Electriptan in acute migraine: A double-blind, placebo-controlled comparison to sumatriptan.
Spierings EL
Neurology; 2000 Sep; 55(5):735; author reply 736. PubMed ID: 10980753
[No Abstract] [Full Text] [Related]
4. [Strong and sustained-acting triptan. Therewith migraine does not return soon].
MMW Fortschr Med; 2003 Aug; 145(31-32):53. PubMed ID: 14524078
[No Abstract] [Full Text] [Related]
5. Triptan therapy in migraine.
Loder E
N Engl J Med; 2010 Jul; 363(1):63-70. PubMed ID: 20592298
[No Abstract] [Full Text] [Related]
6. Treatment options for acute migraine.
Scholz M
RN; 2000 Oct; 63(10):99. PubMed ID: 11062670
[No Abstract] [Full Text] [Related]
7. Evaluating the efficacy of migraine therapy.
Chawluk JB
Postgrad Med; 2000 Sep; 108(3 Suppl):16-21. PubMed ID: 19667526
[TBL] [Abstract][Full Text] [Related]
8. Rizatriptan versus usual care in long-term treatment of migraine.
Silberstein SD
Neurology; 2000; 55(9 Suppl 2):S25-8. PubMed ID: 11089516
[TBL] [Abstract][Full Text] [Related]
9. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan.
Al-Shekhlee A; Reed R
Neurology; 2000 Sep; 55(5):735-6. PubMed ID: 11041768
[No Abstract] [Full Text] [Related]
10. Rizatriptan. Convenience and consistency.
Evans RW
Postgrad Med; 2000 Sep; 108(3 Suppl):10-5. PubMed ID: 19667525
[TBL] [Abstract][Full Text] [Related]
11. [Triptanes in the treatment of migraine. A review based on three Cochrane reviews].
Tfelt-Hansen P; Iversen HK
Ugeskr Laeger; 2006 May; 168(19):1850-3. PubMed ID: 16756800
[No Abstract] [Full Text] [Related]
12. Applying the benefits of the AwM study in the clinic.
Dodick DW
Cephalalgia; 2008 Sep; 28 Suppl 2():42-9. PubMed ID: 18715332
[TBL] [Abstract][Full Text] [Related]
13. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
Pascual J; García-Moncó C; Roig C; Yusta Izquierdo A; López-Gil A;
Headache; 2005 Oct; 45(9):1140-50. PubMed ID: 16178944
[TBL] [Abstract][Full Text] [Related]
14. Early treatment in migraine: how strong is the current evidence?
Gendolla A
Cephalalgia; 2008 Sep; 28 Suppl 2():28-35. PubMed ID: 18715330
[TBL] [Abstract][Full Text] [Related]
15. Nasal sumatriptan: new dosage. For adolescents with migraine: too little benefit.
Prescrire Int; 2005 Apr; 14(76):45-7. PubMed ID: 15875337
[TBL] [Abstract][Full Text] [Related]
16. [Migraine has to be treated. Otherwise a stroke threatens].
MMW Fortschr Med; 2002 Feb; 144(7):70. PubMed ID: 11887744
[No Abstract] [Full Text] [Related]
17. [Therapy of an acute migraine attack. Uniform patient vote for rizatriptan].
MMW Fortschr Med; 2001 Nov; 143(47):52-3. PubMed ID: 11791366
[No Abstract] [Full Text] [Related]
18. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
Goadsby PJ
Cephalalgia; 2008 Sep; 28 Suppl 2():36-41. PubMed ID: 18715331
[TBL] [Abstract][Full Text] [Related]
19. [Cluster headache].
Nissilä M
Duodecim; 2009; 125(1):67-72. PubMed ID: 19341028
[TBL] [Abstract][Full Text] [Related]
20. Frovatriptan and data publication.
Tfelt-Hansen P
Headache; 2008 Oct; 48(9):1382-3. PubMed ID: 19006553
[No Abstract] [Full Text] [Related]
[Next] [New Search]
